Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 3.02, 9.01 · 8-K

NOMAD POWER SOLUTIONS, INC.

Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities

Item 1.01 Entry into a Material Definitive Agreement. On September 28, 2026, Nomad Power Solutions, Inc., (the “Company”), entered into a Note Purchase Agreement (the “Purchase Agreement”) with an Accredited Investor (the “Investor”), pursuant to which the Company agreed to issue and sell in a private placement an aggregate principal amount of $6.57 million Original Issue Discount Secured Promisso…

Filed Sep 30, 2026Accepted Sep 30, 2026, 4:06 PM EDTCIK 1335105Accession 0001493152-26-045104
Share

Company context

We are a clinical-stage biopharmaceutical company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. Our product pipeline is primarily focused on inhibitors of protein phosphatase 2A, which are used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. We believe that inhibitors of protein phosphatases have significant therapeutic potential for a broad range of cancers. We are focusing on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity.

Historical securities (2)

Recent company filings

  1. Regulation FD DisclosureOct 6, 2026
  2. Financial Statements and ExhibitsSep 17, 2026
  3. 10-Q filingAug 14, 2026
  4. SCHEDULE 13G - filed by VANGUARD CAPITAL MANAGEMENT LLC regarding NOMAD POWER SOLUTIONS, INC.Jul 31, 2026
  5. Regulation FD DisclosureJul 31, 2026

Registered securities in this filing

NOMAD POWER SOLUTIONS, INC. · 8-K · Filed 2026-09-30

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.0001 per share

Symbol
NMAD
Exchange
NASDAQ
Classification
COMMON
Filing context

Context: AsOf2026-09-28

Dimensions: Not supplied

Accession 000149315226045104 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 3.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement. On September 28, 2026, Nomad Power Solutions, Inc., (the “Company”), entered into a Note Purchase Agreement (the “Purchase Agreement”) with an Accredited Investor (the “Investor”), pursuant to which the Company agreed to issue and sell in a private placement an aggregate principal amount of $6.57 million Original Issue Discount Secured Promissory Note (the “Note”) for aggregate gross proceeds of $6.0 million. The Note carries an original issue discount of 540,000. In addition, the Company agreed to pay $30,000 to cover fees and expenses. The maturity date of the Note is 12 months from the Purchase Price Date (as defined in the Note) and has an interest rate of nine percent (9%) per year until the Note is paid in full. Beginning on the 6-month anniversary of the Purchase Price Date, the Purchaser has the right, exercisable at any time in its sole and absolute discretion, to redeem up to $800,000 per calendar month by providing written notice to the Company. The Company will have 2 trading days to pay the redemption amount in cash. In connection with the Purchase Agreement, the Company and the Investor entered into a Security Agreement (the “Security Agreement”). Pursuant to the terms of the Security Agreement, the Investor is granted a security interest in the Collateral (as defined in the Security Agreement). The Collateral includes, among other things, all equity interests of the Company, all goods and equipment owned by the Company, all accounts receivable, contract rights, and all other assets, goods and personal property of the Company. Additionally, the Investor, the Company, and the Company’s wholly owned subsidiaries Lixte Biotechnolgy, Inc. (“Lixte”), and Liora Technologies Europe Ltd., (“Liora,” collectively, the Company, Lixte, and Liora, the “Guarantors”, and each individually, a “Guarantor”), entered into a Guaranty Agreement (the “Guaranty Agreement”) for the benefit of the Investor. Pursuant to the Guaranty Agreement, the Guarantors guarantee the indebtedness, liabilities and obligations of the Company to the Investor. The issuance of the Note pursuant to the Purchase Agreement was made pursuant to the exemption from the registration requirements under the Securities Act available to the Company under Section 4(a)(2) and/or Regulation D promulgated thereunder due to the fact the offering of the Note did not involve a public offering of securities. The foregoing description of the Purchase Agreement, the Note, the Security Agreement and the Guaranty do not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase Agreement, the Note, the Security Agreement and the Guaranty Agreement, copies of which are filed as Exhibit 10.1, Exhibit 4.1, Exhibit 10.2 and Exhibit 10.3, respectively to this Current Report on Form 8-K and are incorporated herein by reference.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02 Unregistered Sales of Equity Securities. The information set forth under Item 1.01 of this Current Report on Form 8-K regarding the issuance of the Note is incorporated herein by reference. The Company offered and sold the Note in reliance upon exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), including Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The issuance of the Note did not involve a public offering, and the Investor acquired the Note for investment purposes and not with a view toward distribution.
Filed exhibits (1)
EX-4.1 (by filename) ex4-1.htm

Exhibit 4.1 SECURED PROMISSORY NOTE September 28, 2026 U.S. $6,570,000.00 FOR VALUE RECEIVED, Nomad Power Solutions, Inc., a Delaware corporation (“ Borrower ”), hereby unconditionally promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (“ Lender ”), $6,570,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is twelve (12) months after the Purchase Price Date (the “ Maturity Date ”) in accordance with the terms set forth herein and to pay interest on the Outstanding Balance at the rate of nine percent (9%) per annum from the Purchase Price Date until the same is paid in full. All interest calculations hereunder shall be computed on the basis of a 360-day year comprised of twelve (12) thirty (30) day months, shall compound daily and shall be payable in accordance with the terms of this Note. This Secured Promissory Note (this “ Note ”) is issued and made effective as of the date set forth above (the “ Effective Date ”). This Note is issued pursuant to that certain Note Purchase Agreement dated September 28, 2026 by and between Borrower and Lender (the “ Purchase Agreement ”). Cer…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.